Osteoporosis pathogenesis and treatment: existing and emerging avenues
Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporo...
Saved in:
Published in | Cellular & molecular biology letters Vol. 27; no. 1; pp. 72 - 26 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
04.09.2022
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporosis are believed to be due to the increased activity of osteoclasts, decreased activity of osteoblasts, or both, which leads to an imbalance in the bone remodeling process with accelerated bone resorption and attenuated bone formation. Currently, the available clinical treatments for osteoporosis have mostly focused on factors influencing bone remodeling; however, they have their own limitations and side effects. Recently, cytokine immunotherapy, gene therapy, and stem cell therapy have become new approaches for the treatment of various diseases. This article reviews the latest research on bone remodeling mechanisms, as well as how this underpins current and potential novel treatments for osteoporosis. |
---|---|
AbstractList | Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporosis are believed to be due to the increased activity of osteoclasts, decreased activity of osteoblasts, or both, which leads to an imbalance in the bone remodeling process with accelerated bone resorption and attenuated bone formation. Currently, the available clinical treatments for osteoporosis have mostly focused on factors influencing bone remodeling; however, they have their own limitations and side effects. Recently, cytokine immunotherapy, gene therapy, and stem cell therapy have become new approaches for the treatment of various diseases. This article reviews the latest research on bone remodeling mechanisms, as well as how this underpins current and potential novel treatments for osteoporosis. Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporosis are believed to be due to the increased activity of osteoclasts, decreased activity of osteoblasts, or both, which leads to an imbalance in the bone remodeling process with accelerated bone resorption and attenuated bone formation. Currently, the available clinical treatments for osteoporosis have mostly focused on factors influencing bone remodeling; however, they have their own limitations and side effects. Recently, cytokine immunotherapy, gene therapy, and stem cell therapy have become new approaches for the treatment of various diseases. This article reviews the latest research on bone remodeling mechanisms, as well as how this underpins current and potential novel treatments for osteoporosis.Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporosis are believed to be due to the increased activity of osteoclasts, decreased activity of osteoblasts, or both, which leads to an imbalance in the bone remodeling process with accelerated bone resorption and attenuated bone formation. Currently, the available clinical treatments for osteoporosis have mostly focused on factors influencing bone remodeling; however, they have their own limitations and side effects. Recently, cytokine immunotherapy, gene therapy, and stem cell therapy have become new approaches for the treatment of various diseases. This article reviews the latest research on bone remodeling mechanisms, as well as how this underpins current and potential novel treatments for osteoporosis. Abstract Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporosis are believed to be due to the increased activity of osteoclasts, decreased activity of osteoblasts, or both, which leads to an imbalance in the bone remodeling process with accelerated bone resorption and attenuated bone formation. Currently, the available clinical treatments for osteoporosis have mostly focused on factors influencing bone remodeling; however, they have their own limitations and side effects. Recently, cytokine immunotherapy, gene therapy, and stem cell therapy have become new approaches for the treatment of various diseases. This article reviews the latest research on bone remodeling mechanisms, as well as how this underpins current and potential novel treatments for osteoporosis. |
ArticleNumber | 72 |
Author | Liang, Bo Lin, Shu Burley, George Shi, Yan-Chuan |
Author_xml | – sequence: 1 givenname: Bo surname: Liang fullname: Liang, Bo – sequence: 2 givenname: George orcidid: 0000-0002-2560-3604 surname: Burley fullname: Burley, George – sequence: 3 givenname: Shu surname: Lin fullname: Lin, Shu – sequence: 4 givenname: Yan-Chuan orcidid: 0000-0002-8368-6735 surname: Shi fullname: Shi, Yan-Chuan |
BookMark | eNp9kU9P3DAQxa2KqsC2X6CnPXJJ8dhOYnNAqlD5IyFxac_WxJkEo8RebC9qv32zu3Cgh57sGfv95mneKTsKMRBjX4F_A9DNeQZoal1xISrOZQuV_MBOoNGmAmnE0XJXoq401PKYneb8xLngSvFP7Fg2vNZG8RN2_ZALxU1MMfu83mB5jCMF2hUY-nVJhGWmUC7W9Nvn4sO479NMadwXLxS2lD-zjwNOmb68niv26_rHz6vb6v7h5u7q-33laoBSGUQclFYIousdOSkNNdDLrgVoO8XR1IRcgNMDSdVq0aFyxvC2l6bvnJArdnfg9hGf7Cb5GdMfG9HbfSOm0WIq3k1kTa-JhpYAAZTulRkG2emOOz40oJfZK3Z5YG223UyLnVASTu-g71-Cf7RjfLFGKeDKLICzV0CKz8sSip19djRNGChusxUtNwZAmJ1vffjqlkXnRIN1vmDxcUf2kwVud5HaQ6R2idTuI7VykYp_pG8O_yP6C5R1prg |
CitedBy_id | crossref_primary_10_1186_s11658_023_00489_y crossref_primary_10_3390_biom13061006 crossref_primary_10_3389_fmed_2024_1436486 crossref_primary_10_1007_s12015_023_10558_6 crossref_primary_10_1007_s11657_025_01509_4 crossref_primary_10_1016_j_yexcr_2024_114138 crossref_primary_10_20473_joints_v13i1_2024_1_11 crossref_primary_10_1186_s12951_024_02412_9 crossref_primary_10_1002_jum_16371 crossref_primary_10_1016_j_ijbiomac_2023_125879 crossref_primary_10_1080_14656566_2025_2451741 crossref_primary_10_1177_10225536231187181 crossref_primary_10_1038_s41526_024_00382_8 crossref_primary_10_2217_bmm_2022_0621 crossref_primary_10_1177_09731296241296201 crossref_primary_10_1186_s12906_023_04167_6 crossref_primary_10_1186_s13018_023_04494_x crossref_primary_10_1186_s43042_024_00587_2 crossref_primary_10_1021_acs_jnatprod_4c00640 crossref_primary_10_1002_cpdd_1440 crossref_primary_10_1038_s41413_023_00283_8 crossref_primary_10_3389_fbioe_2023_1303678 crossref_primary_10_3389_fmed_2023_1235081 crossref_primary_10_1016_j_exger_2024_112614 crossref_primary_10_1016_j_mtbio_2025_101558 crossref_primary_10_1080_13697137_2025_2471059 crossref_primary_10_5483_BMBRep_2023_0054 crossref_primary_10_1016_j_xcrm_2022_100881 crossref_primary_10_1016_j_archoralbio_2024_106062 crossref_primary_10_1016_j_jot_2024_08_010 crossref_primary_10_4252_wjsc_v16_i2_151 crossref_primary_10_1186_s12891_024_07761_y crossref_primary_10_1186_s12863_024_01269_z crossref_primary_10_1186_s12951_024_02829_2 crossref_primary_10_3389_fcimb_2024_1367325 crossref_primary_10_3390_nu16183130 crossref_primary_10_1007_s13577_025_01180_4 crossref_primary_10_1002_kjm2_12937 crossref_primary_10_3390_nu15040919 crossref_primary_10_3390_nu17020262 crossref_primary_10_3389_fphys_2024_1411148 crossref_primary_10_1016_j_heliyon_2024_e38818 crossref_primary_10_3389_fmed_2023_1289144 crossref_primary_10_3389_fphar_2023_1242194 crossref_primary_10_1002_advs_202307388 crossref_primary_10_3389_fbioe_2023_1162263 crossref_primary_10_1016_j_ijbiomac_2025_142254 crossref_primary_10_3892_mmr_2023_13033 crossref_primary_10_12677_acm_2024_14102796 crossref_primary_10_1186_s11658_023_00420_5 crossref_primary_10_1038_s41598_024_51957_0 crossref_primary_10_12677_acm_2024_143916 crossref_primary_10_1002_wnan_1885 crossref_primary_10_3390_nu15143233 crossref_primary_10_1080_14740338_2024_2419995 crossref_primary_10_3389_fvets_2025_1555779 crossref_primary_10_3390_ijms242115772 crossref_primary_10_1016_j_ijscr_2023_107978 crossref_primary_10_3390_ph15111432 crossref_primary_10_3390_pharmaceutics15010220 crossref_primary_10_1016_j_jtcme_2023_08_001 crossref_primary_10_1186_s13287_023_03317_4 crossref_primary_10_1186_s40659_024_00494_1 crossref_primary_10_2174_0118715303257269231011073100 crossref_primary_10_1002_adfm_202417810 crossref_primary_10_1016_j_bbrc_2024_149858 crossref_primary_10_1016_j_ijbiomac_2024_136504 crossref_primary_10_1515_jom_2023_0174 crossref_primary_10_3389_fbioe_2025_1541746 crossref_primary_10_1016_j_cscee_2024_101080 crossref_primary_10_1016_j_heliyon_2024_e36566 crossref_primary_10_1177_00368504241300723 crossref_primary_10_1007_s43465_023_01042_x crossref_primary_10_3389_fcell_2023_1276098 crossref_primary_10_1016_j_intimp_2023_109745 crossref_primary_10_1021_acscentsci_3c01212 crossref_primary_10_1016_j_jare_2024_05_024 crossref_primary_10_1007_s00198_024_07150_0 crossref_primary_10_1007_s12033_024_01316_1 crossref_primary_10_1038_s41413_023_00306_4 crossref_primary_10_1038_s41564_023_01586_6 crossref_primary_10_3390_molecules28041693 crossref_primary_10_1016_j_heliyon_2024_e27870 crossref_primary_10_1016_j_xphs_2024_04_005 crossref_primary_10_3389_fendo_2025_1469400 crossref_primary_10_3390_ijerph20042923 crossref_primary_10_1186_s13018_025_05513_9 crossref_primary_10_3390_foods14010020 crossref_primary_10_1186_s11658_023_00452_x crossref_primary_10_1016_j_cellsig_2025_111598 crossref_primary_10_1021_acs_jmedchem_3c00114 |
Cites_doi | 10.1002/JLB.5VMA0219-054R 10.1002/advs.202003390 10.1097/00007611-200194060-00004 10.1016/j.maturitas.2017.04.008 10.1002/jcp.26592 10.1016/j.bone.2019.115104 10.1016/j.jot.2022.01.003 10.1038/s41584-022-00764-w 10.1016/j.stemcr.2020.05.008 10.1016/j.bone.2015.07.006 10.1016/j.tem.2012.03.008 10.4158/GL-2020-0524SUPPL 10.1186/s11658-019-0136-2 10.1016/j.jsbmb.2017.01.021 10.1016/j.jos.2016.12.021 10.1038/s41419-019-1942-1 10.1186/s11658-019-0177-6 10.1007/s00198-015-3109-y 10.3390/ijms22179452 10.1080/15476286.2018.1445959 10.1186/s40659-020-00309-z 10.1093/hmg/ddy386 10.1038/cdd.2015.99 10.1002/jbm4.10041 10.1038/s41467-018-08097-7 10.1111/jcpe.13051 10.1152/physrev.00066.2017 10.1007/s00418-018-1636-2 10.1038/s41413-018-0035-6 10.4110/in.2018.18.e8 10.1155/2020/6910312 10.3390/ijms21238887 10.1038/labinvest.2017.60 10.1016/j.arr.2022.101608 10.3390/ijms21144923 10.1038/nm.3668 10.1530/EJE-18-0113 10.1016/j.bone.2020.115566 10.1007/s40266-018-0525-7 10.3892/etm.2017.4712 10.1097/MED.0000000000000501 10.3390/nu5093605 10.1007/978-981-13-1117-8_13 10.1302/2046-3758.61.BJR-2016-0085.R1 10.1080/14656566.2020.1717468 10.1038/nrendo.2016.164 10.1016/j.ijbiomac.2019.09.084 10.1016/j.bone.2020.115474 10.1007/s00018-016-2425-5 10.1210/er.2015-1114 10.1016/j.biomaterials.2012.05.024 10.1002/jcb.28810 10.15252/embr.202152481 10.1016/j.ydbio.2011.11.013 10.1007/s11914-019-00502-4 10.1007/s00198-013-2469-4 10.1038/nature04303 10.1007/s11914-013-0171-2 10.1016/j.cell.2021.02.002 10.1111/j.1582-4934.2011.01335.x 10.1016/j.pharmthera.2012.07.009 10.1016/S2213-8587(17)30138-9 10.1016/j.bone.2007.04.174 10.1186/s13018-019-1430-4 10.1016/j.coph.2013.02.002 10.1007/s00109-021-02164-1 10.1111/j.1365-2184.2010.00674.x 10.2174/1574888X13666180410160511 10.1002/jbmr.3708 10.1007/s00281-019-00761-4 10.1007/s00198-003-1583-0 10.1016/j.cca.2018.05.035 10.1097/PPO.0b013e31819e332a 10.1097/GME.0000000000001585 10.1007/s11914-020-00652-w 10.1016/j.bbrc.2015.03.059 10.3803/EnM.2018.33.3.318 10.1016/j.ejphar.2015.03.028 10.1111/jcmm.15229 10.1007/164_2019_338 10.1159/000486060 10.1002/jcb.28143 10.1186/1479-5876-10-11 10.1074/jbc.M601000200 10.1016/j.maturitas.2011.11.010 10.1007/164_2019_329 10.1155/2019/1730978 10.3389/fcell.2020.00433 10.1056/NEJMoa1708322 10.1016/j.jcyt.2014.07.009 10.1097/BOR.0000000000000449 10.1021/acs.nanolett.9b00287 10.1016/j.msec.2017.05.035 10.1016/j.bioactmat.2021.09.015 10.1007/s11657-016-0278-z 10.7150/ijms.21666 10.1186/s11658-016-0013-1 10.1210/jc.2017-02585 10.1016/j.pharmthera.2020.107473 10.1177/0192623317735316 10.1007/s11914-018-0451-y 10.1038/cddis.2014.4 10.1038/nmeth1079 10.1111/bcp.13867 10.1016/j.bone.2005.08.019 10.1016/j.bioactmat.2021.11.012 10.1002/advs.202102286 10.3389/fgene.2019.01044 10.1089/ten.teb.2016.0454 10.1152/physrev.00028.2017 10.3390/ijms19020360 10.1016/S0140-6736(18)32112-3 10.1002/jbmr.2032 10.1001/jamanetworkopen.2019.17789 10.5966/sctm.2013-0090 10.1016/j.biopha.2019.108960 10.1038/s41591-018-0005-y 10.1016/j.pharmthera.2022.108168 10.1038/s41574-019-0282-7 10.3389/fendo.2020.00430 10.1186/s11658-021-00291-8 10.1002/jcb.25026 10.1172/JCI154888 10.1016/j.bbrc.2018.09.187 10.1016/j.cnur.2020.02.002 10.1038/nature13145 10.1007/s00198-018-4573-y 10.1042/BST20200243 10.1016/j.msec.2017.05.042 10.1371/journal.pone.0039365 10.1016/S2213-8587(19)30346-8 10.1080/14712598.2017.1280455 10.1007/s00198-021-06024-z 10.1186/s12891-020-3077-z 10.3390/ijms20194925 10.1038/s41591-018-0020-z 10.1111/bcp.13869 10.1111/jcmm.15153 10.1016/j.bone.2014.08.004 10.3892/etm.2015.2477 10.3390/ijms22126564 10.1002/jcp.26856 10.1002/advs.202004831 10.1007/s00264-012-1543-4 10.1002/iub.2131 10.1016/j.cmet.2017.01.001 10.1080/13697137.2019.1568403 10.3906/sag-2003-127 10.1007/s00223-017-0331-y 10.1177/0004563218759371 10.1016/S2213-8587(22)00012-2 10.1016/j.bjan.2019.08.004 10.1016/j.bone.2016.10.007 10.1038/mt.2009.153 10.1089/scd.2012.0327 10.1038/boneres.2016.30 10.3389/fendo.2018.00303 10.1038/s41419-019-1353-3 10.1002/jbm4.10115 10.1007/164_2020_354 10.1371/journal.pone.0149400 10.1007/s00198-018-4414-z 10.1016/j.bone.2014.04.019 10.3390/ijms22010434 10.1177/0022034519854704 10.3390/molecules23123144 10.1101/cshperspect.a031237 10.1016/j.steroids.2014.12.010 10.3389/fimmu.2019.02925 10.1016/j.clinbiochem.2012.05.006 10.1038/s41574-022-00649-8 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: The Author(s) 2022 |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1186/s11658-022-00371-3 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1689-1392 |
EndPage | 26 |
ExternalDocumentID | oai_doaj_org_article_9d8eef7e1a1148d49ff3b8b0c0f618ec PMC9441049 10_1186_s11658_022_00371_3 |
Genre | Correspondence Review |
GrantInformation_xml | – fundername: ; grantid: 2021N033S; 2020CT003 – fundername: ; grantid: 1162276 – fundername: ; grantid: 2020BSH04 |
GroupedDBID | --- .86 .VR 06D 0R~ 0VY 29B 2JY 2~H 30V 4.4 408 53G 5GY 67N 67Z 6NX 6S1 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95. 95~ AAFWJ AAJSJ AAKDD AAQCX AASML AASQH AAXMT AAYXX ABAQN ABFKT ABMNI ABUWG ACGFS ACOMO ACPRK ACZBO ADBBV ADGYE ADOZN ADUKV AENEX AFBAA AFBBN AFCXV AFKRA AFPKN AFWTZ AHBYD AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BA0 BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC C6C CCPQU CITATION CS3 DU5 E3Z EBLON EBS EMOBN F5P FRP FYUFA G-Y G-Z GQ7 GROUPED_DOAJ GX1 HCIFZ HF~ HLICF HMCUK HMJXF HYE IJ- IXC IXE IY9 IZQ I~X I~Z KDC KOV M1P M7P MA- N9A OAM OK1 PF0 PHGZM PHGZT PIMPY PSQYO Q2X QOS R9I RBZ RNS ROL RPM RPX RSV S27 S3A S3B SBL SDH SHX SOJ T13 TR2 TSK TSV TUC U2A UKHRP VC2 WK8 XSB Y2W ~A9 7X8 PPXIY PQGLB 5PM PJZUB PUEGO |
ID | FETCH-LOGICAL-c511t-9aaaf484a12bdcec339e61d3b7117b40a95ea021c8fe34782ba4c9907d39dbc23 |
IEDL.DBID | DOA |
ISSN | 1425-8153 1689-1392 |
IngestDate | Wed Aug 27 01:28:22 EDT 2025 Thu Aug 21 18:30:05 EDT 2025 Thu Jul 10 19:25:10 EDT 2025 Tue Jul 01 03:25:17 EDT 2025 Thu Apr 24 23:04:35 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c511t-9aaaf484a12bdcec339e61d3b7117b40a95ea021c8fe34782ba4c9907d39dbc23 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23 ObjectType-Review-2 |
ORCID | 0000-0002-2560-3604 0000-0002-8368-6735 |
OpenAccessLink | https://doaj.org/article/9d8eef7e1a1148d49ff3b8b0c0f618ec |
PMID | 36058940 |
PQID | 2709911292 |
PQPubID | 23479 |
PageCount | 26 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9d8eef7e1a1148d49ff3b8b0c0f618ec pubmedcentral_primary_oai_pubmedcentral_nih_gov_9441049 proquest_miscellaneous_2709911292 crossref_citationtrail_10_1186_s11658_022_00371_3 crossref_primary_10_1186_s11658_022_00371_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20220904 |
PublicationDateYYYYMMDD | 2022-09-04 |
PublicationDate_xml | – month: 9 year: 2022 text: 20220904 day: 4 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Cellular & molecular biology letters |
PublicationYear | 2022 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | R Lv (371_CR97) 2019; 116 X Ye (371_CR167) 2014; 16 Y Yang (371_CR13) 2020; 53 V Volarevic (371_CR162) 2018; 15 T Wang (371_CR32) 2020; 21 ML Zou (371_CR45) 2021; 8 JY Li (371_CR98) 2019; 23 MT Drake (371_CR144) 2017; 38 JH Du (371_CR40) 2019; 98 X Qin (371_CR49) 2019; 28 I Shymanskyi (371_CR56) 2018; 9 J Cui (371_CR28) 2020; 24 X Tu (371_CR51) 2012; 362 B Soós (371_CR125) 2022; 18 Z Yu (371_CR171) 2012; 36 V Paspaliaris (371_CR14) 2019; 2019 P Pludowski (371_CR127) 2018; 175 AP Hermann (371_CR133) 2013; 13 A Marahleh (371_CR34) 2019; 10 J Li (371_CR85) 2015; 460 S Ma (371_CR87) 2019; 120 H Song (371_CR108) 2019; 19 J Yazdani (371_CR142) 2019; 69 A Anesi (371_CR29) 2019; 20 K Ke (371_CR90) 2015; 81 IE Adamopoulos (371_CR16) 2018; 30 Q Zeng (371_CR79) 2019; 24 HL Fu (371_CR84) 2016; 20 JA Kanis (371_CR4) 2016; 11 X Shi (371_CR100) 2019; 18 R Xu (371_CR110) 2018; 24 L Li (371_CR11) 2018; 1086 S Onodera (371_CR48) 2020; 15 371_CR2 CM Karner (371_CR42) 2017; 74 AS Qadir (371_CR82) 2015; 116 DL Sietsema (371_CR1) 2020; 55 JY Reginster (371_CR160) 2015; 26 T Ono (371_CR20) 2018; 149 C Fixen (371_CR154) 2021; 19 J Yu (371_CR53) 2020; 138 D Naot (371_CR61) 2019; 99 MS Ebert (371_CR181) 2007; 4 EK Osnes (371_CR3) 2004; 15 S Qin (371_CR24) 2017; 14 L Osagie-Clouard (371_CR151) 2017; 6 C Götherström (371_CR169) 2014; 3 P Anagnostis (371_CR9) 2017; 101 M Monajemi (371_CR36) 2019; 106 HC Blair (371_CR38) 2017; 23 Y Xu (371_CR52) 2018; 233 D Goltzman (371_CR60) 2018; 50 S Song (371_CR122) 2022; 237 R Kocijan (371_CR78) 2020; 131 K Sawakami (371_CR41) 2006; 281 DS Amarasekara (371_CR33) 2018; 18 C Matsumoto (371_CR65) 2006; 38 TL Yang (371_CR69) 2020; 16 MN Weitzmann (371_CR17) 2017; 45 JA Stone (371_CR145) 2019; 85 J Cui (371_CR121) 2022; 77 M Augustine (371_CR149) 2013; 11 L Bandeira (371_CR66) 2017; 17 B Kołodziejska (371_CR156) 2021; 22 AD Anastasilakis (371_CR152) 2020; 21 Y Jang (371_CR31) 2021; 22 M Zhu (371_CR118) 2021; 32 J Li (371_CR107) 2022; 100 Y Han (371_CR76) 2019; 14 YC Hou (371_CR129) 2018; 484 FY Fan (371_CR83) 2019; 18 MN Wein (371_CR59) 2018; 8 A Zarei (371_CR57) 2016; 4 P D'Amelio (371_CR73) 2018; 102 F Du (371_CR101) 2015; 10 S Weske (371_CR116) 2018; 24 MC Moorer (371_CR43) 2018; 33 T Komori (371_CR120) 2015; 759 BZ Leder (371_CR147) 2018; 2 Z Saidak (371_CR157) 2012; 136 B Abrahamsen (371_CR159) 2014; 25 C Chen (371_CR96) 2014; 29 Y Sun (371_CR93) 2018; 234 JE Compston (371_CR19) 2019; 393 P Yao (371_CR128) 2019; 2 J Garcia (371_CR46) 2021; 143 N Yin (371_CR88) 2019; 24 VK Cheng (371_CR105) 2019; 3 HP Liu (371_CR182) 2019; 23 VA Levin (371_CR12) 2018; 29 F Li (371_CR15) 2016; 11 X Zhi (371_CR27) 2020; 24 J Kureel (371_CR102) 2014; 5 DM Anita Sanghani-Kerai (371_CR163) 2018; 13 J Phetfong (371_CR106) 2016; 21 JT Taiani (371_CR170) 2014; 64 JS Kenkre (371_CR5) 2018; 55 H Xie (371_CR115) 2014; 20 M De Martinis (371_CR113) 2020; 21 HG Zhang (371_CR81) 2019; 23 S Cremers (371_CR6) 2019; 85 T Komori (371_CR50) 2020; 43 S Muruganandan (371_CR70) 2018; 16 L Hu (371_CR37) 2018; 19 WS Lian (371_CR95) 2019; 10 X Chen (371_CR68) 2018; 6 ED Deeks (371_CR7) 2018; 35 Y Cui (371_CR185) 2022; 10 H Li (371_CR104) 2015; 22 JR Center (371_CR132) 2020; 141 Z Mao (371_CR91) 2019; 71 FP Li (371_CR75) 2018; 22 R Dai (371_CR143) 2020; 8 Y Fan (371_CR150) 2017; 25 L Wang (371_CR30) 2020; 142 HJ Liao (371_CR25) 2019; 10 H Chen (371_CR111) 2019; 10 O Lamy (371_CR148) 2019; 17 J Delgado-Calle (371_CR153) 2017; 96 R Brommage (371_CR140) 2020; 262 UH Lerner (371_CR21) 2019; 46 RE Mäkitie (371_CR77) 2018; 103 F Alshahrani (371_CR130) 2013; 5 L Zheng (371_CR184) 2022; 14 L Zhou (371_CR26) 2020; 21 K Urbanek (371_CR54) 2017; 97 M Pilmane (371_CR158) 2017; 78 FS Hsiao (371_CR166) 2010; 43 SK Ramchand (371_CR18) 2020; 262 C Shi (371_CR94) 2014; 68 XB Mo (371_CR119) 2018; 29 Y Xiao (371_CR92) 2018; 17 C Zhang (371_CR175) 2017; 79 JF Lima (371_CR179) 2018; 15 S Khosla (371_CR62) 2012; 23 AZ Bluming (371_CR135) 2009; 15 L You (371_CR174) 2012; 10 Z Qiu (371_CR117) 2022; 33 AM Havens (371_CR172) 2013; 22 M Agostino (371_CR39) 2020; 48 JA Cauley (371_CR63) 2015; 99 X Li (371_CR103) 2018; 120 PM Camacho (371_CR10) 2020; 26 XY He (371_CR72) 2021; 26 JW Lowery (371_CR44) 2018; 98 S Christakos (371_CR55) 2020; 262 M Tobeiha (371_CR22) 2020; 2020 M Bottani (371_CR80) 2019; 10 G Mazziotti (371_CR124) 2022; 18 HY Liu (371_CR165) 2012; 33 R Aggarwal (371_CR173) 2012; 7 KG Saag (371_CR155) 2017; 377 AP Kusumbe (371_CR109) 2014; 507 K Zhu (371_CR126) 2012; 45 B Arjmand (371_CR161) 2020; 11 C Dou (371_CR178) 2021; 8 T Vilaca (371_CR64) 2022; 10 Z Ilyas (371_CR134) 2019; 26 MR McClung (371_CR146) 2019; 7 SW Cho (371_CR168) 2009; 17 I Chiodini (371_CR131) 2018; 178 K Inoue (371_CR177) 2019; 41 M Hadjiargyrou (371_CR176) 2019; 34 HT Chen (371_CR164) 2012; 16 HG Bone (371_CR8) 2017; 5 S Palacios (371_CR138) 2012; 71 RA Lobo (371_CR136) 2017; 13 JH Liu (371_CR137) 2020; 27 L Meloni (371_CR35) 2018; 23 JC Lin (371_CR86) 2018; 506 Z Bal (371_CR47) 2020; 50 QQ Wan (371_CR71) 2021; 8 J Krützfeldt (371_CR180) 2005; 438 Y Hu (371_CR67) 2021; 22 MM McDonald (371_CR23) 2021; 184 S Tanaka (371_CR141) 2017; 22 C Shi (371_CR183) 2020; 207 YS Chen (371_CR74) 2020; 21 JH Liu (371_CR114) 2021; 8 YC Shi (371_CR58) 2007; 41 B Luo (371_CR99) 2019; 23 371_CR123 S Wang (371_CR89) 2020; 21 JV Pinkerton (371_CR139) 2019; 22 KD Seely (371_CR112) 2021; 22 |
References_xml | – volume: 106 start-page: 863 issue: 4 year: 2019 ident: 371_CR36 publication-title: J Leukoc Biol doi: 10.1002/JLB.5VMA0219-054R – volume: 18 start-page: 6339 issue: 6 year: 2019 ident: 371_CR83 publication-title: Oncol Lett – volume: 8 start-page: 2003390 issue: 7 year: 2021 ident: 371_CR71 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202003390 – ident: 371_CR2 doi: 10.1097/00007611-200194060-00004 – volume: 101 start-page: 23 year: 2017 ident: 371_CR9 publication-title: Maturitas doi: 10.1016/j.maturitas.2017.04.008 – volume: 233 start-page: 6921 issue: 10 year: 2018 ident: 371_CR52 publication-title: J Cell Physiol doi: 10.1002/jcp.26592 – volume: 131 year: 2020 ident: 371_CR78 publication-title: Bone doi: 10.1016/j.bone.2019.115104 – volume: 33 start-page: 55 year: 2022 ident: 371_CR117 publication-title: J Orthop Translat doi: 10.1016/j.jot.2022.01.003 – volume: 18 start-page: 249 issue: 5 year: 2022 ident: 371_CR125 publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-022-00764-w – volume: 15 start-page: 125 issue: 1 year: 2020 ident: 371_CR48 publication-title: Stem Cell Rep doi: 10.1016/j.stemcr.2020.05.008 – volume: 81 start-page: 237 year: 2015 ident: 371_CR90 publication-title: Bone doi: 10.1016/j.bone.2015.07.006 – volume: 23 start-page: 576 issue: 11 year: 2012 ident: 371_CR62 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2012.03.008 – volume: 26 start-page: 1 issue: Suppl 1 year: 2020 ident: 371_CR10 publication-title: Endocr Pract doi: 10.4158/GL-2020-0524SUPPL – volume: 24 start-page: 11 year: 2019 ident: 371_CR79 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-019-0136-2 – volume: 175 start-page: 125 year: 2018 ident: 371_CR127 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2017.01.021 – volume: 22 start-page: 536 issue: 3 year: 2017 ident: 371_CR141 publication-title: J Orthop Sci doi: 10.1016/j.jos.2016.12.021 – volume: 10 start-page: 705 issue: 10 year: 2019 ident: 371_CR95 publication-title: Cell Death Dis doi: 10.1038/s41419-019-1942-1 – volume: 24 start-page: 51 year: 2019 ident: 371_CR88 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-019-0177-6 – volume: 26 start-page: 1667 issue: 6 year: 2015 ident: 371_CR160 publication-title: Osteoporos Int doi: 10.1007/s00198-015-3109-y – volume: 22 start-page: 9452 issue: 17 year: 2021 ident: 371_CR112 publication-title: Int J Mol Sci doi: 10.3390/ijms22179452 – volume: 15 start-page: 338 issue: 3 year: 2018 ident: 371_CR179 publication-title: RNA Biol doi: 10.1080/15476286.2018.1445959 – volume: 53 start-page: 40 issue: 1 year: 2020 ident: 371_CR13 publication-title: Biol Res doi: 10.1186/s40659-020-00309-z – volume: 28 start-page: 896 issue: 6 year: 2019 ident: 371_CR49 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddy386 – volume: 22 start-page: 1935 issue: 12 year: 2015 ident: 371_CR104 publication-title: Cell Death Differ doi: 10.1038/cdd.2015.99 – volume: 2 start-page: 62 issue: 2 year: 2018 ident: 371_CR147 publication-title: JBMR Plus doi: 10.1002/jbm4.10041 – volume: 10 start-page: 181 issue: 1 year: 2019 ident: 371_CR111 publication-title: Nat Commun doi: 10.1038/s41467-018-08097-7 – volume: 46 start-page: 33 issue: Suppl 21 year: 2019 ident: 371_CR21 publication-title: J Clin Periodontol doi: 10.1111/jcpe.13051 – volume: 99 start-page: 781 issue: 1 year: 2019 ident: 371_CR61 publication-title: Physiol Rev doi: 10.1152/physrev.00066.2017 – volume: 149 start-page: 325 issue: 4 year: 2018 ident: 371_CR20 publication-title: Histochem Cell Biol doi: 10.1007/s00418-018-1636-2 – volume: 6 start-page: 34 year: 2018 ident: 371_CR68 publication-title: Bone Res doi: 10.1038/s41413-018-0035-6 – volume: 18 issue: 1 year: 2018 ident: 371_CR33 publication-title: Immune Netw doi: 10.4110/in.2018.18.e8 – volume: 2020 start-page: 6910312 year: 2020 ident: 371_CR22 publication-title: Biomed Res Int doi: 10.1155/2020/6910312 – volume: 21 start-page: 8887 issue: 23 year: 2020 ident: 371_CR113 publication-title: Int J Mol Sci doi: 10.3390/ijms21238887 – volume: 97 start-page: 1225 issue: 10 year: 2017 ident: 371_CR54 publication-title: Lab Invest doi: 10.1038/labinvest.2017.60 – volume: 77 year: 2022 ident: 371_CR121 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2022.101608 – volume: 21 start-page: 4923 issue: 14 year: 2020 ident: 371_CR74 publication-title: Int J Mol Sci doi: 10.3390/ijms21144923 – volume: 20 start-page: 1270 issue: 11 year: 2014 ident: 371_CR115 publication-title: Nat Med doi: 10.1038/nm.3668 – volume: 178 start-page: D13 issue: 4 year: 2018 ident: 371_CR131 publication-title: Eur J Endocrinol doi: 10.1530/EJE-18-0113 – volume: 141 year: 2020 ident: 371_CR132 publication-title: Bone doi: 10.1016/j.bone.2020.115566 – volume: 35 start-page: 163 issue: 2 year: 2018 ident: 371_CR7 publication-title: Drugs Aging doi: 10.1007/s40266-018-0525-7 – volume: 14 start-page: 1475 issue: 2 year: 2017 ident: 371_CR24 publication-title: Exp Ther Med doi: 10.3892/etm.2017.4712 – volume: 26 start-page: 335 issue: 6 year: 2019 ident: 371_CR134 publication-title: Curr Opin Endocrinol Diabetes Obes doi: 10.1097/MED.0000000000000501 – volume: 5 start-page: 3605 issue: 9 year: 2013 ident: 371_CR130 publication-title: Nutrients doi: 10.3390/nu5093605 – volume: 1086 start-page: 199 year: 2018 ident: 371_CR11 publication-title: Adv Exp Med Biol doi: 10.1007/978-981-13-1117-8_13 – volume: 20 start-page: 3911 issue: 18 year: 2016 ident: 371_CR84 publication-title: Eur Rev Med Pharmacol Sci – volume: 6 start-page: 14 issue: 1 year: 2017 ident: 371_CR151 publication-title: Bone Joint Res. doi: 10.1302/2046-3758.61.BJR-2016-0085.R1 – volume: 21 start-page: 477 issue: 4 year: 2020 ident: 371_CR152 publication-title: Expert Opin Pharmacother doi: 10.1080/14656566.2020.1717468 – volume: 13 start-page: 220 issue: 4 year: 2017 ident: 371_CR136 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2016.164 – volume: 142 start-page: 142 year: 2020 ident: 371_CR30 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2019.09.084 – volume: 138 year: 2020 ident: 371_CR53 publication-title: Bone doi: 10.1016/j.bone.2020.115474 – volume: 74 start-page: 1649 issue: 9 year: 2017 ident: 371_CR42 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-016-2425-5 – volume: 38 start-page: 325 issue: 4 year: 2017 ident: 371_CR144 publication-title: Endocr Rev doi: 10.1210/er.2015-1114 – volume: 33 start-page: 6105 issue: 26 year: 2012 ident: 371_CR165 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.05.024 – volume: 120 start-page: 15429 issue: 9 year: 2019 ident: 371_CR87 publication-title: J Cell Biochem doi: 10.1002/jcb.28810 – volume: 22 issue: 7 year: 2021 ident: 371_CR67 publication-title: EMBO Rep doi: 10.15252/embr.202152481 – volume: 362 start-page: 76 issue: 1 year: 2012 ident: 371_CR51 publication-title: Dev Biol doi: 10.1016/j.ydbio.2011.11.013 – volume: 17 start-page: 8 issue: 1 year: 2019 ident: 371_CR148 publication-title: Curr Osteoporos Rep doi: 10.1007/s11914-019-00502-4 – volume: 25 start-page: 757 issue: 2 year: 2014 ident: 371_CR159 publication-title: Osteoporos Int doi: 10.1007/s00198-013-2469-4 – volume: 438 start-page: 685 issue: 7068 year: 2005 ident: 371_CR180 publication-title: Nature doi: 10.1038/nature04303 – volume: 11 start-page: 400 issue: 4 year: 2013 ident: 371_CR149 publication-title: Curr Osteoporos Rep doi: 10.1007/s11914-013-0171-2 – volume: 184 start-page: 1330 issue: 5 year: 2021 ident: 371_CR23 publication-title: Cell doi: 10.1016/j.cell.2021.02.002 – volume: 16 start-page: 582 issue: 3 year: 2012 ident: 371_CR164 publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2011.01335.x – volume: 136 start-page: 216 issue: 2 year: 2012 ident: 371_CR157 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2012.07.009 – volume: 5 start-page: 513 issue: 7 year: 2017 ident: 371_CR8 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(17)30138-9 – volume: 41 start-page: 87 issue: 1 year: 2007 ident: 371_CR58 publication-title: Bone doi: 10.1016/j.bone.2007.04.174 – volume: 14 start-page: 416 issue: 1 year: 2019 ident: 371_CR76 publication-title: J Orthop Surg Res doi: 10.1186/s13018-019-1430-4 – volume: 13 start-page: 435 issue: 3 year: 2013 ident: 371_CR133 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2013.02.002 – volume: 143 start-page: 1 issue: 115791 year: 2021 ident: 371_CR46 publication-title: Bone – volume: 23 start-page: 6791 issue: 16 year: 2019 ident: 371_CR99 publication-title: Eur Rev Med Pharmacol Sci – volume: 100 start-page: 167 issue: 2 year: 2022 ident: 371_CR107 publication-title: J Mol Med (Berl) doi: 10.1007/s00109-021-02164-1 – volume: 43 start-page: 235 issue: 3 year: 2010 ident: 371_CR166 publication-title: Cell Prolif doi: 10.1111/j.1365-2184.2010.00674.x – volume: 13 start-page: 369 issue: 5 year: 2018 ident: 371_CR163 publication-title: Curr Stem Cell Res Therapy. doi: 10.2174/1574888X13666180410160511 – volume: 34 start-page: 797 issue: 5 year: 2019 ident: 371_CR176 publication-title: J Bone Miner Res doi: 10.1002/jbmr.3708 – volume: 41 start-page: 573 issue: 5 year: 2019 ident: 371_CR177 publication-title: Semin Immunopathol doi: 10.1007/s00281-019-00761-4 – volume: 15 start-page: 567 issue: 7 year: 2004 ident: 371_CR3 publication-title: Osteoporos Int doi: 10.1007/s00198-003-1583-0 – volume: 484 start-page: 179 year: 2018 ident: 371_CR129 publication-title: Clin Chim Acta doi: 10.1016/j.cca.2018.05.035 – volume: 15 start-page: 93 issue: 2 year: 2009 ident: 371_CR135 publication-title: Cancer J doi: 10.1097/PPO.0b013e31819e332a – volume: 27 start-page: 1171 issue: 10 year: 2020 ident: 371_CR137 publication-title: Menopause doi: 10.1097/GME.0000000000001585 – volume: 19 start-page: 15 issue: 1 year: 2021 ident: 371_CR154 publication-title: Curr Osteoporos Rep doi: 10.1007/s11914-020-00652-w – volume: 460 start-page: 482 issue: 2 year: 2015 ident: 371_CR85 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2015.03.059 – volume: 33 start-page: 318 issue: 3 year: 2018 ident: 371_CR43 publication-title: Endocrinol Metab (Seoul) doi: 10.3803/EnM.2018.33.3.318 – volume: 759 start-page: 287 year: 2015 ident: 371_CR120 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2015.03.028 – volume: 24 start-page: 6149 issue: 11 year: 2020 ident: 371_CR28 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15229 – volume: 262 start-page: 47 year: 2020 ident: 371_CR55 publication-title: Handb Exp Pharmacol doi: 10.1007/164_2019_338 – volume: 50 start-page: 1 year: 2018 ident: 371_CR60 publication-title: Front Horm Res doi: 10.1159/000486060 – volume: 23 start-page: 456 year: 2019 ident: 371_CR81 publication-title: Eur Rev Med Pharmacol Sci – volume: 120 start-page: 8561 year: 2018 ident: 371_CR103 publication-title: J Cell Biochem doi: 10.1002/jcb.28143 – volume: 10 start-page: 11 year: 2012 ident: 371_CR174 publication-title: J Transl Med doi: 10.1186/1479-5876-10-11 – volume: 281 start-page: 23698 issue: 33 year: 2006 ident: 371_CR41 publication-title: J Biol Chem doi: 10.1074/jbc.M601000200 – volume: 71 start-page: 194 issue: 2 year: 2012 ident: 371_CR138 publication-title: Maturitas doi: 10.1016/j.maturitas.2011.11.010 – volume: 262 start-page: 451 year: 2020 ident: 371_CR140 publication-title: Handb Exp Pharmacol doi: 10.1007/164_2019_329 – volume: 2019 start-page: 1730978 year: 2019 ident: 371_CR14 publication-title: Stem Cells Int doi: 10.1155/2019/1730978 – volume: 8 start-page: 433 year: 2020 ident: 371_CR143 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00433 – volume: 377 start-page: 1417 issue: 15 year: 2017 ident: 371_CR155 publication-title: N Engl J Med doi: 10.1056/NEJMoa1708322 – volume: 16 start-page: 1643 issue: 12 year: 2014 ident: 371_CR167 publication-title: Cytotherapy doi: 10.1016/j.jcyt.2014.07.009 – volume: 30 start-page: 59 issue: 1 year: 2018 ident: 371_CR16 publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000449 – volume: 19 start-page: 3040 issue: 5 year: 2019 ident: 371_CR108 publication-title: Nano Lett doi: 10.1021/acs.nanolett.9b00287 – volume: 79 start-page: 296 year: 2017 ident: 371_CR175 publication-title: Mater Sci Eng C Mater Biol Appl doi: 10.1016/j.msec.2017.05.035 – volume: 10 start-page: 207 year: 2022 ident: 371_CR185 publication-title: Bioact Mater doi: 10.1016/j.bioactmat.2021.09.015 – volume: 11 start-page: 25 issue: 1 year: 2016 ident: 371_CR4 publication-title: Arch Osteoporos doi: 10.1007/s11657-016-0278-z – volume: 15 start-page: 36 issue: 1 year: 2018 ident: 371_CR162 publication-title: Int J Med Sci doi: 10.7150/ijms.21666 – volume: 21 start-page: 12 year: 2016 ident: 371_CR106 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-016-0013-1 – volume: 103 start-page: 1985 issue: 5 year: 2018 ident: 371_CR77 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2017-02585 – volume: 207 year: 2020 ident: 371_CR183 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2020.107473 – volume: 45 start-page: 911 issue: 7 year: 2017 ident: 371_CR17 publication-title: Toxicol Pathol doi: 10.1177/0192623317735316 – volume: 16 start-page: 434 issue: 4 year: 2018 ident: 371_CR70 publication-title: Curr Osteoporos Rep doi: 10.1007/s11914-018-0451-y – volume: 5 issue: 2 year: 2014 ident: 371_CR102 publication-title: Cell Death Dis doi: 10.1038/cddis.2014.4 – volume: 4 start-page: 721 issue: 9 year: 2007 ident: 371_CR181 publication-title: Nat Methods doi: 10.1038/nmeth1079 – volume: 85 start-page: 1052 issue: 6 year: 2019 ident: 371_CR6 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.13867 – volume: 38 start-page: 220 issue: 2 year: 2006 ident: 371_CR65 publication-title: Bone doi: 10.1016/j.bone.2005.08.019 – volume: 14 start-page: 250 year: 2022 ident: 371_CR184 publication-title: Bioact Mater doi: 10.1016/j.bioactmat.2021.11.012 – volume: 8 issue: 15 year: 2021 ident: 371_CR178 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202102286 – volume: 18 start-page: 2393 issue: 4 year: 2019 ident: 371_CR100 publication-title: Exp Ther Med – volume: 10 start-page: 1044 year: 2019 ident: 371_CR80 publication-title: Front Genet doi: 10.3389/fgene.2019.01044 – volume: 43 start-page: 168 issue: 2 year: 2020 ident: 371_CR50 publication-title: Mol Cells – volume: 23 start-page: 268 issue: 3 year: 2017 ident: 371_CR38 publication-title: Tissue Eng Part B Rev doi: 10.1089/ten.teb.2016.0454 – volume: 98 start-page: 2431 issue: 4 year: 2018 ident: 371_CR44 publication-title: Physiol Rev doi: 10.1152/physrev.00028.2017 – volume: 23 start-page: 6394 issue: 15 year: 2019 ident: 371_CR98 publication-title: Eur Rev Med Pharmacol Sci – volume: 19 start-page: 360 issue: 2 year: 2018 ident: 371_CR37 publication-title: Int J Mol Sci doi: 10.3390/ijms19020360 – volume: 393 start-page: 364 issue: 10169 year: 2019 ident: 371_CR19 publication-title: Lancet doi: 10.1016/S0140-6736(18)32112-3 – volume: 29 start-page: 338 issue: 2 year: 2014 ident: 371_CR96 publication-title: J Bone Miner Res doi: 10.1002/jbmr.2032 – volume: 2 issue: 12 year: 2019 ident: 371_CR128 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2019.17789 – volume: 3 start-page: 255 issue: 2 year: 2014 ident: 371_CR169 publication-title: Stem Cells Transl Med doi: 10.5966/sctm.2013-0090 – volume: 116 year: 2019 ident: 371_CR97 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2019.108960 – volume: 24 start-page: 667 issue: 5 year: 2018 ident: 371_CR116 publication-title: Nat Med doi: 10.1038/s41591-018-0005-y – volume: 237 year: 2022 ident: 371_CR122 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2022.108168 – volume: 16 start-page: 91 issue: 2 year: 2020 ident: 371_CR69 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-019-0282-7 – volume: 11 start-page: 430 year: 2020 ident: 371_CR161 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2020.00430 – volume: 26 start-page: 47 issue: 1 year: 2021 ident: 371_CR72 publication-title: Cell Mol Biol Lett doi: 10.1186/s11658-021-00291-8 – volume: 116 start-page: 730 issue: 5 year: 2015 ident: 371_CR82 publication-title: J Cell Biochem doi: 10.1002/jcb.25026 – ident: 371_CR123 doi: 10.1172/JCI154888 – volume: 506 start-page: 194 issue: 1 year: 2018 ident: 371_CR86 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2018.09.187 – volume: 55 start-page: 193 issue: 2 year: 2020 ident: 371_CR1 publication-title: Nurs Clin North Am doi: 10.1016/j.cnur.2020.02.002 – volume: 507 start-page: 323 issue: 7492 year: 2014 ident: 371_CR109 publication-title: Nature doi: 10.1038/nature13145 – volume: 29 start-page: 2029 issue: 9 year: 2018 ident: 371_CR119 publication-title: Osteoporos Int doi: 10.1007/s00198-018-4573-y – volume: 48 start-page: 1765 issue: 4 year: 2020 ident: 371_CR39 publication-title: Biochem Soc Trans doi: 10.1042/BST20200243 – volume: 78 start-page: 1222 year: 2017 ident: 371_CR158 publication-title: Mater Sci Eng C Mater Biol Appl doi: 10.1016/j.msec.2017.05.042 – volume: 7 issue: 6 year: 2012 ident: 371_CR173 publication-title: PLoS ONE doi: 10.1371/journal.pone.0039365 – volume: 22 start-page: 7439 issue: 21 year: 2018 ident: 371_CR75 publication-title: Eur Rev Med Pharmacol Sci – volume: 7 start-page: 899 issue: 12 year: 2019 ident: 371_CR146 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(19)30346-8 – volume: 17 start-page: 255 issue: 2 year: 2017 ident: 371_CR66 publication-title: Expert Opin Biol Ther doi: 10.1080/14712598.2017.1280455 – volume: 32 start-page: 2493 issue: 12 year: 2021 ident: 371_CR118 publication-title: Osteoporos Int doi: 10.1007/s00198-021-06024-z – volume: 21 start-page: 112 issue: 1 year: 2020 ident: 371_CR26 publication-title: BMC Musculoskelet Disord doi: 10.1186/s12891-020-3077-z – volume: 20 start-page: 4925 issue: 19 year: 2019 ident: 371_CR29 publication-title: Int J Mol Sci doi: 10.3390/ijms20194925 – volume: 24 start-page: 823 issue: 6 year: 2018 ident: 371_CR110 publication-title: Nat Med doi: 10.1038/s41591-018-0020-z – volume: 85 start-page: 1072 issue: 6 year: 2019 ident: 371_CR145 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.13869 – volume: 24 start-page: 5122 issue: 9 year: 2020 ident: 371_CR27 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15153 – volume: 68 start-page: 67 year: 2014 ident: 371_CR94 publication-title: Bone doi: 10.1016/j.bone.2014.08.004 – volume: 23 start-page: 9754 issue: 22 year: 2019 ident: 371_CR182 publication-title: Eur Rev Med Pharmacol Sci – volume: 10 start-page: 207 issue: 1 year: 2015 ident: 371_CR101 publication-title: Exp Ther Med doi: 10.3892/etm.2015.2477 – volume: 22 start-page: 6564 issue: 12 year: 2021 ident: 371_CR156 publication-title: Int J Mol Sci doi: 10.3390/ijms22126564 – volume: 17 start-page: 7789 issue: 6 year: 2018 ident: 371_CR92 publication-title: Mol Med Rep – volume: 234 start-page: 231 issue: 1 year: 2018 ident: 371_CR93 publication-title: J Cell Physiol doi: 10.1002/jcp.26856 – volume: 8 start-page: 2004831 issue: 9 year: 2021 ident: 371_CR114 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202004831 – volume: 36 start-page: 2163 issue: 10 year: 2012 ident: 371_CR171 publication-title: Int Orthop doi: 10.1007/s00264-012-1543-4 – volume: 71 start-page: 1916 issue: 12 year: 2019 ident: 371_CR91 publication-title: IUBMB Life doi: 10.1002/iub.2131 – volume: 25 start-page: 661 issue: 3 year: 2017 ident: 371_CR150 publication-title: Cell Metab doi: 10.1016/j.cmet.2017.01.001 – volume: 22 start-page: 140 issue: 2 year: 2019 ident: 371_CR139 publication-title: Climacteric doi: 10.1080/13697137.2019.1568403 – volume: 50 start-page: 1707 year: 2020 ident: 371_CR47 publication-title: Turk J Med Sci doi: 10.3906/sag-2003-127 – volume: 102 start-page: 415 issue: 4 year: 2018 ident: 371_CR73 publication-title: Calcif Tissue Int doi: 10.1007/s00223-017-0331-y – volume: 55 start-page: 308 issue: 3 year: 2018 ident: 371_CR5 publication-title: Ann Clin Biochem doi: 10.1177/0004563218759371 – volume: 10 start-page: 273 issue: 4 year: 2022 ident: 371_CR64 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(22)00012-2 – volume: 69 start-page: 594 issue: 6 year: 2019 ident: 371_CR142 publication-title: Braz J Anesthesiol doi: 10.1016/j.bjan.2019.08.004 – volume: 96 start-page: 29 year: 2017 ident: 371_CR153 publication-title: Bone doi: 10.1016/j.bone.2016.10.007 – volume: 17 start-page: 1979 issue: 11 year: 2009 ident: 371_CR168 publication-title: Mol Ther doi: 10.1038/mt.2009.153 – volume: 22 start-page: 622 issue: 4 year: 2013 ident: 371_CR172 publication-title: Stem Cells Dev doi: 10.1089/scd.2012.0327 – volume: 4 start-page: 16030 year: 2016 ident: 371_CR57 publication-title: Bone Res doi: 10.1038/boneres.2016.30 – volume: 9 start-page: 1 year: 2018 ident: 371_CR56 publication-title: Front Endocrinol (Lausanne). doi: 10.3389/fendo.2018.00303 – volume: 21 start-page: 213 issue: 3 year: 2020 ident: 371_CR32 publication-title: Curr Drug Targets – volume: 10 start-page: 77 issue: 2 year: 2019 ident: 371_CR25 publication-title: Cell Death Dis doi: 10.1038/s41419-019-1353-3 – volume: 8 start-page: 1 year: 2021 ident: 371_CR45 publication-title: Front Mol Biosci – volume: 3 start-page: 2 issue: 1 year: 2019 ident: 371_CR105 publication-title: JBMR Plus doi: 10.1002/jbm4.10115 – volume: 262 start-page: 423 year: 2020 ident: 371_CR18 publication-title: Handb Exp Pharmacol doi: 10.1007/164_2020_354 – volume: 11 issue: 2 year: 2016 ident: 371_CR15 publication-title: PLoS ONE doi: 10.1371/journal.pone.0149400 – volume: 29 start-page: 1049 issue: 5 year: 2018 ident: 371_CR12 publication-title: Osteoporos Int doi: 10.1007/s00198-018-4414-z – volume: 64 start-page: 263 year: 2014 ident: 371_CR170 publication-title: Bone doi: 10.1016/j.bone.2014.04.019 – volume: 22 start-page: 434 issue: 1 year: 2021 ident: 371_CR31 publication-title: Int J Mol Sci doi: 10.3390/ijms22010434 – volume: 21 start-page: 1125 issue: 3 year: 2020 ident: 371_CR89 publication-title: Mol Med Rep – volume: 98 start-page: 930 issue: 8 year: 2019 ident: 371_CR40 publication-title: J Dent Res doi: 10.1177/0022034519854704 – volume: 23 start-page: 3144 issue: 12 year: 2018 ident: 371_CR35 publication-title: Molecules doi: 10.3390/molecules23123144 – volume: 8 start-page: a031237 issue: 8 year: 2018 ident: 371_CR59 publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a031237 – volume: 99 start-page: 11 issue: Pt A year: 2015 ident: 371_CR63 publication-title: Steroids doi: 10.1016/j.steroids.2014.12.010 – volume: 10 start-page: 1 year: 2019 ident: 371_CR34 publication-title: Front Immunol doi: 10.3389/fimmu.2019.02925 – volume: 45 start-page: 936 issue: 12 year: 2012 ident: 371_CR126 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2012.05.006 – volume: 18 start-page: 353 issue: 6 year: 2022 ident: 371_CR124 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-022-00649-8 |
SSID | ssj0020440 |
Score | 2.5965734 |
Snippet | Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe,... Abstract Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 72 |
SubjectTerms | Bone formation Bone remodeling Bone resorption MicroRNA-based therapy Osteoporosis Pathogenesis Review Letter |
Title | Osteoporosis pathogenesis and treatment: existing and emerging avenues |
URI | https://www.proquest.com/docview/2709911292 https://pubmed.ncbi.nlm.nih.gov/PMC9441049 https://doaj.org/article/9d8eef7e1a1148d49ff3b8b0c0f618ec |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4-ELyIT1wfSwVvEmybtEm8qbgsgquIwt5CkqYqSCvu7sF_70zaXexFL0IvSdM2nUwy35DJN4ScKh57IVVChcs8hQXPUGNlTLnjpcuUhQsPJ9-N8uEzvx1n4x-pvjAmrKEHbgR3rgrpfSl8YhC5F1yVJbPSxi4u80R6h6sv2Ly5M9W6WphIOZwrSjMqYVLPj8vI_HyChDOSYhR74KujrGOSAnN_B252gyV_WJ_BJtloYWN02XR3iyz5apusNYkkv3bI4B4GqwYoXU_eJhFmGa5fcBGDgqmKaBFNfhEh8yVGOod6PBz8Egqw5EE3dsnz4ObpekjbDAnUAVCaUmWMKbnkJkktdNAxpnyeFMyKJBGWx0Zl3oAVd7L0jAMYsIY7sD-iYKqwLmV7ZKWqK79PInhLkZU5SNYEJ89g3ipXGAdNU4DhPZLMhaRdSx-OWSzedXAjZK4bwWoQrA6C1axHzhbPfDTkGb-2vkLZL1oi8XWoAHXQrTrov9ShR07mI6dhouDuh6l8PZvoVAAYRnQJvyI6Q9r5YvdO9fYaKLcVoEbwpQ7-o4uHZD0N2oe7UkdkZfo588eAbKa2T5bFWPTJ6tXN6OGxH1T6GyoY-Pg |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Osteoporosis+pathogenesis+and+treatment%3A+existing+and+emerging+avenues&rft.jtitle=Cellular+%26+molecular+biology+letters&rft.au=Liang%2C+Bo&rft.au=Burley%2C+George&rft.au=Lin%2C+Shu&rft.au=Shi%2C+Yan-Chuan&rft.date=2022-09-04&rft.pub=BioMed+Central&rft.issn=1425-8153&rft.eissn=1689-1392&rft.volume=27&rft_id=info:doi/10.1186%2Fs11658-022-00371-3&rft_id=info%3Apmid%2F36058940&rft.externalDocID=PMC9441049 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1425-8153&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1425-8153&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1425-8153&client=summon |